Clemente C - Search Results

1

Immunohistochemical analysis of the T-cell receptor beta-chain variable regions expressed by T lymphocytes infiltrating primary human melanoma.

Clemente C, Rao S, Lupetti R, Tragni G, Pisarra P, Bersani I, Parmiani G, Mihm MC Jr, Sensi M. Clemente C, et al. Lab Invest. 1998 May;78(5):619-27. Lab Invest. 1998. PMID: 9605186

2

Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.

Mihm MC Jr, Clemente CG, Cascinelli N. Mihm MC Jr, et al. Among authors: clemente cg. Lab Invest. 1996 Jan;74(1):43-7. Lab Invest. 1996. PMID: 8569196

3

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.

Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Clemente CG, et al. Cancer. 1996 Apr 1;77(7):1303-10. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5. Cancer. 1996. PMID: 8608507 Free article.

4

Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas.

Salvi S, Segalla F, Rao S, Arienti F, Sartori M, Bratina G, Caronni E, Anichini A, Clemente C, Parmiani G, et al. Salvi S, et al. Among authors: clemente c. Cancer Res. 1995 Aug 1;55(15):3374-9. Cancer Res. 1995. PMID: 7614474

5

N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma.

Lupetti R, Sensi M, Mortarini R, Anichini A, Clemente C, Parmiani G. Lupetti R, et al. Among authors: clemente c. Melanoma Res. 1994 Feb;4(1):11-9. doi: 10.1097/00008390-199402000-00003. Melanoma Res. 1994. PMID: 8032213

6

Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes.

Taramelli D, Mazzocchi A, Clemente C, Fossati G, Parmiani G. Taramelli D, et al. Among authors: clemente c. Cancer Immunol Immunother. 1988;26(1):61-6. doi: 10.1007/BF00199849. Cancer Immunol Immunother. 1988. PMID: 3345538

7

Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme.

Clemente C, Cochran AJ, Elder DE, Levene A, MacKie RM, Mihm MC, Rilke F, Cascinelli N, Fitzpatrick TB, Sober AJ. Clemente C, et al. Hum Pathol. 1991 Apr;22(4):313-9. doi: 10.1016/0046-8177(91)90078-4. Hum Pathol. 1991. PMID: 1741810 Free article.

8

Biological activity and clinical efficacy of intravenous high-dose thymopentin in metastatic melanoma patients.

Clemente C, Belli F, Mascheroni L, Bufalino R, Rao S, Baldini MT, Mihm MC Jr, Cascinelli N. Clemente C, et al. Melanoma Res. 1996 Feb;6(1):63-9. doi: 10.1097/00008390-199602000-00009. Melanoma Res. 1996. PMID: 8640072 Clinical Trial.

9

Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability.

Belli F, Arienti F, Sulé-Suso J, Clemente C, Mascheroni L, Cattelan A, Santantonio C, Gallino GF, Melani C, Rao S, Colombo MP, Maio M, Cascinelli N, Parmiani G. Belli F, et al. Among authors: clemente c. Cancer Immunol Immunother. 1997 Jun;44(4):197-203. doi: 10.1007/s002620050373. Cancer Immunol Immunother. 1997. PMID: 9222277 Clinical Trial.

10

A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.

Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, Piris A, Mihm MC Jr. Clemente C, et al. Pathologica. 2009 Oct;101(5):169-74. Pathologica. 2009. PMID: 20218056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page